Medicare Enrolled

Dr. Birgit Amann, M.D.

Child & Adolescent Psychiatry Physician · Troy, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1639 E BIG BEAVER RD, Troy, MI 48083
2485289000
In practice since 2006 (20 years)
NPI: 1386663789 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amann? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Amann

Dr. Birgit Amann is a child & adolescent psychiatry physician in Troy, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Amann performed 216 Medicare services across 59 unique beneficiaries.

Between the years covered by Open Payments, Dr. Amann received a total of $927,863 from 39 pharmaceutical and/or device companies across 1660 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in child & adolescent psychiatry physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Amann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 35% volume in MI $927,863 industry payments

Medicare Practice Summary

Medicare Utilization ↗
216
Medicare services
Top 35% in MI for child & adolescent psychiatry physician
59
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
216 $51 $119
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$927,863
Total received (2018-2024)
Avg $132,552/year across 7 years
Top 2% in MI for child & adolescent psychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
1,660
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$834,417 (89.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$88,279 (9.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,167 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$204,771
2023
$189,187
2022
$131,603
2021
$52,173
2020
$53,596
2019
$193,107
2018
$103,426

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$87,284
ABBVIE INC.
$37,714
Noven Pharmaceuticals, Inc.
$29,278
Otsuka Pharmaceutical Development & Commercialization, Inc.
$13,581
Otsuka America Pharmaceutical, Inc.
$11,856
Axsome Therapeutics, Inc.
$11,825
Corium, LLC
$7,916
IRONSHORE PHARMACEUTICALS INC.
$4,755
Janssen Pharmaceuticals, Inc
$186
E.R. Squibb & Sons, L.L.C.
$122
Tris Pharma Inc
$77
Noven Therapeutics, LLC
$61
Takeda Pharmaceuticals U.S.A., Inc.
$56
Validus Pharmaceuticals LLC
$45
Lundbeck LLC
$14
Top 3 companies account for 75.3% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$374,801
Ironshore Pharmaceuticals Inc.
$181,923
Otsuka America Pharmaceutical, Inc.
$53,425
Tris Pharma Inc
$49,310
Corium, LLC
$40,009
ABBVIE INC.
$37,786
Noven Pharmaceuticals, Inc.
$37,627
Axsome Therapeutics, Inc.
$33,723
AbbVie Inc.
$20,261
Rhodes Pharmaceuticals L.P.
$18,956
Otsuka Pharmaceutical Development & Commercialization, Inc.
$18,576
Neos Therapeutics, LP
$17,163
Adlon Therapeutics L.P.
$13,677
Takeda Pharmaceuticals U.S.A., Inc.
$8,098
Shire North American Group Inc
$7,748
IRONSHORE PHARMACEUTICALS INC.
$4,755
Janssen Pharmaceuticals, Inc
$4,717
Corium, Inc.
$900
Validus Pharmaceuticals LLC
$835
Lundbeck LLC
$705
Sunovion Pharmaceuticals Inc.
$486
Allergan Inc.
$475
Purdue Pharma L.P.
$428
ITI, Inc.
$212
Alkermes, Inc.
$191
Allergan, Inc.
$186
Teva Pharmaceuticals USA, Inc.
$163
Bausch Health US, LLC
$138
E.R. Squibb & Sons, L.L.C.
$122
ARBOR PHARMACEUTICALS, INC.
$89
Neurocrine Biosciences, Inc.
$69
OWP Pharmaceuticals, Inc.
$62
Noven Therapeutics, LLC
$61
IDORSIA PHARMACEUTICALS US INC
$50
LivaNova USA, Inc.
$43
Vertical Pharmaceuticals, LLC
$35
Merck Sharp & Dohme Corporation
$24
Eisai Inc.
$20
PFIZER INC.
$12
Top 3 companies account for 65.8% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · Dayvigo · Dyanavel XR · Equetro · Evekeo · Evekeo ODT · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · METHYLPHENIDATE 72 · MYDAYIS · Onyda XR · QELBREE · QUILLICHEW ER · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · Quillivant XR · REXULTI · SPRAVATO · SUBVENITE · TRINTELLIX · Trintellix · UZEDY · VIIBRYD · VNS - Symmetry · VRAYLAR · VYVANSE · WELLBUTRIN · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in child & adolescent psychiatry physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for child & adolescent psychiatry physician in MI.

Looking for a child & adolescent psychiatry physician in Troy?
Compare child & adolescent psychiatry physicians in the Troy area by procedure volume, costs, and industry payment transparency.
Browse child & adolescent psychiatry physicians nearby

Geographic Context

Child & adolescent psychiatry physicians within 10 mi
57
Per 100K population
4.5
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL, TROY
3.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Amann is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Amann experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Amann performed 216 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amann receive payments from pharmaceutical companies?
Yes. Dr. Amann received a total of $927,863 from 39 companies across 1,660 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amann's costs compare to other child & adolescent psychiatry physicians in Troy?
Dr. Amann's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →